Package 60505-4129-5

{"route": ["ORAL"], "spl_id": "f106ef3d-7def-b2e5-2428-60ecd16326f0", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0360505412976", "0360505413072", "0360505412877"], "unii": ["VZI5B1W380"], "rxcui": ["1365653", "1365842", "1365844"], "spl_set_id": ["a20e4a95-8ee1-e702-003e-e353ec1ee133"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4129-5)", "package_ndc": "60505-4129-5", "marketing_start_date": "20240903"}, {"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4129-7)", "package_ndc": "60505-4129-7", "marketing_start_date": "20240903"}], "brand_name": "OXCARBAZEPINE", "product_id": "60505-4129_f106ef3d-7def-b2e5-2428-60ecd16326f0", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "60505-4129", "generic_name": "OXCARBAZEPINE", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXCARBAZEPINE", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "300 mg/1"}], "application_number": "ANDA213369", "marketing_category": "ANDA", "marketing_start_date": "20240903", "listing_expiration_date": "20261231"}